PSTV

#4003
PLUS THERAPEUTICS, Inc. - Common Stock
5.8 2 USD
-9.49%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
5.82
5.82
Rango anual
0.13
8.00
Cambio diario
-9.49%
Variación mensual
+4.49%
Variación en los últimos 6 meses
+854.10%
Cambio anual
+1906.90%
Cierres anteriores
6.4 3
Open
5.8 2
Mínimo
5.8 2
High
5.8 2
Volumen
22
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

PLUS THERAPEUTICS, Inc. - Common Stock

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Noticias